Avinger Reports Third Quarter 2019 Financial Results
05 nov. 2019 16h01 HE
|
Avinger, Inc.
Increased Utilization Drives 33% Growth in Catheter Sales and Gross Margin ExpansionTotal Pantheris Revenue Increases 81% Year-over-Year REDWOOD CITY, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) --...
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock
21 août 2019 21h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced the pricing of...
Avinger Reports 26% Sequential Revenue Growth in Second Quarter 2019
31 juil. 2019 16h01 HE
|
Avinger, Inc.
Revenue Growth Fuels Strong Operating MetricsPantheris SV Limited Launch at Key U.S. Sites in July REDWOOD CITY, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a...
Avinger Announces Pantheris SV Limited Launch and Successful Treatment of First Patients in the United States
29 juil. 2019 08h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,...
Avinger to Announce Second Quarter 2019 Financial Results on July 31, 2019
26 juil. 2019 09h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., July 26, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,...
Avinger to Effect One-for-Ten Reverse Stock Split
21 juin 2019 16h05 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., June 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for...
Avinger Provides First Quarter 2019 Shareholder Update
08 mai 2019 16h01 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based...
Avinger Receives FDA Clearance of Pantheris SV Device
10 avr. 2019 08h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with...
Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update
06 mars 2019 16h05 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,...
Avinger to Announce Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019
28 févr. 2019 08h30 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,...